GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (BOM:532890) » Definitions » Cyclically Adjusted PS Ratio

Take Solutions (BOM:532890) Cyclically Adjusted PS Ratio : (As of May. 31, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Take Solutions Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Take Solutions Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Take Solutions's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions Cyclically Adjusted PS Ratio Chart

Take Solutions Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.39 0.25 0.12 0.19

Take Solutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.19 - - -

Competitive Comparison of Take Solutions's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Take Solutions's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Take Solutions's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Take Solutions's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Take Solutions's Cyclically Adjusted PS Ratio falls into.


;
;

Take Solutions Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Take Solutions's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Take Solutions's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0/158.3229*158.3229
=0.000

Current CPI (Dec. 2024) = 158.3229.

Take Solutions Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 17.872 97.163 29.122
201506 19.040 99.841 30.193
201509 19.873 101.753 30.921
201512 20.453 102.901 31.469
201603 25.675 102.518 39.651
201606 26.185 105.961 39.125
201609 22.741 105.961 33.979
201612 25.517 105.196 38.404
201703 29.696 105.196 44.693
201706 26.795 107.109 39.607
201709 28.278 109.021 41.066
201712 31.063 109.404 44.953
201803 34.052 109.786 49.106
201806 31.947 111.317 45.437
201809 35.198 115.142 48.398
201812 35.591 115.142 48.938
201903 36.347 118.202 48.684
201906 39.791 120.880 52.116
201909 40.813 123.175 52.459
201912 43.921 126.235 55.085
202003 26.571 124.705 33.734
202006 11.343 127.000 14.141
202009 11.673 130.118 14.203
202012 14.790 130.889 17.890
202103 14.893 131.771 17.894
202106 14.405 134.084 17.009
202109 13.631 135.847 15.886
202112 14.184 138.161 16.254
202203 2.637 138.822 3.007
202206 3.941 142.347 4.383
202209 3.064 144.661 3.353
202212 3.492 145.763 3.793
202303 2.572 146.865 2.773
202306 0.240 150.280 0.253
202309 0.004 151.492 0.004
202312 0.000 152.924 0.000
202403 4.158 153.035 4.302
202406 0.000 155.789 0.000
202409 0.000 157.882 0.000
202412 0.000 158.323 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Take Solutions  (BOM:532890) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Take Solutions Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Take Solutions's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Take Solutions Business Description

Traded in Other Exchanges
Address
No.56, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Take Solutions Ltd is a technology-driven clinical research organization supporting pharma, biotech, and devices companies. It offers a combination of full-service Clinical Research, Generics Development, Data Sciences, Regulatory Affairs, and Pharmacovigilance and Safety services. The company operates in a single segment; Life Sciences and Support Services.

Take Solutions Headlines

No Headlines